Goldstein M, Kuga S, Shimizu Y, Meller E
Adv Exp Med Biol. 1986;204:189-95. doi: 10.1007/978-1-4684-5191-7_12.
The administration of the D1 DA receptor antagonist SCH 23390 produces catalepsy in rat, and this behavior can be abolished by pretreatment with selective D2 DA receptor agonists. The administration of mixed D1/D2 DA agonists, but not of selective D2 DA agonists, produces SMB behavior in monkeys with surgical unilateral VMT lesions of the brain stem. The DA agonist-induced SMB behavior is abolished by pretreatment of the monkeys with either the D1 DA antagonist SCH 23390 or with the mixed D1/D2 antagonist fluphenazine, but not with the selective D2 antagonist (+/-) sulpiride. A hypothetical relationship between abnormal guanine nucleotide metabolism in Lesch-Nyhan syndrome and the development of DA receptor supersensitivity is presented. The possible role of abnormal guanine nucleotide metabolism in some mental disorders associated with DA dysfunctions is discussed.
给予D1多巴胺受体拮抗剂SCH 23390可使大鼠产生僵住症,而这种行为可通过预先给予选择性D2多巴胺受体激动剂而消除。给予混合的D1/D2多巴胺激动剂而非选择性D2多巴胺激动剂,可在患有脑干手术单侧腹侧被盖区损伤的猴子中产生刻板运动行为(SMB)。多巴胺激动剂诱导的SMB行为可通过预先给予猴子D1多巴胺拮抗剂SCH 23390或混合的D1/D2拮抗剂氟奋乃静而消除,但不能通过选择性D2拮抗剂(±)舒必利消除。本文提出了莱施-奈恩综合征中鸟嘌呤核苷酸代谢异常与多巴胺受体超敏反应发生之间的假设关系。讨论了鸟嘌呤核苷酸代谢异常在一些与多巴胺功能障碍相关的精神障碍中的可能作用。